Kishor Bhatia
Chief Tech/Sci/R&D Officer at LANTERN PHARMA INC.
Net worth: - $ as of 29/04/2024
Profile
Kishor G.
Bhatia is currently the Chief Scientific Officer at Lantern Pharma, Inc. He previously worked as the Director-AIDS Malignancy Program at the National Cancer Institute from 2007 to 2016.
Before that, he was a Research Assistant Professor at Georgetown University from 1985 to 1989.
He holds a doctorate degree from the University of Mumbai and an undergraduate degree from the University of Pune.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
LANTERN PHARMA, INC.
-.--% | 14/04/2024 | 0 ( -.--% ) | - $ | 29/04/2024 |
Kishor Bhatia active positions
| Companies | Position | Start |
|---|---|---|
| LANTERN PHARMA INC. | Chief Tech/Sci/R&D Officer | 30/11/2019 |
Former positions of Kishor Bhatia
| Companies | Position | End |
|---|---|---|
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | 30/06/2016 |
| Georgetown University | Corporate Officer/Principal | 31/12/1988 |
Training of Kishor Bhatia
| University of Pune | Undergraduate Degree |
| University of Mumbai | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| LANTERN PHARMA INC. | Health Technology |
| Private companies | 1 |
|---|---|
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
- Stock Market
- Insiders
- Kishor Bhatia
